WHO supports Malawi’s US$437.9M Global Fund funding request for 2027–2030
The proposal, developed under the Global Fund’s Grant Cycle 8 (GC8), seeks US$339.6 million for HIV, US$16.1 million for TB and US$82.2 million for malaria.
MALAWI – The World Health Organization (WHO) is supporting Malawi’s preparation of a US$437.9 million funding request to the Global Fund for HIV, tuberculosis (TB), malaria and health system investments covering July 2027 to June 2030.
The proposal, developed under the Global Fund’s Grant Cycle 8 (GC8), seeks US$339.6 million for HIV, US$16.1 million for TB, and US$82.2 million for malaria.
It also allocates 10% of each disease component to strengthening resilient and sustainable health systems, including the capacity to deliver essential services.
WHO is part of the national technical writing team, working alongside the Ministry of Health, the Country Coordinating Mechanism, disease control programmes, civil society organisations and development partners.
Its role includes providing technical guidance, reviewing proposal sections, strengthening the use of epidemiological and programme data, and addressing technical questions raised during the application process.
Technical review strengthens funding proposal
The agency has also organised and facilitated several mock Technical Review Panels (TRPs) to assess the proposal before submission.
These exercises brought together national and international experts to examine the application’s technical design, financial planning, strategic priorities and implementation arrangements.
The reviews identified areas requiring further attention and provided recommendations to improve programme prioritisation, address gaps and strengthen the proposed investments.
They also helped align disease-specific interventions with broader health system priorities.
Malawi’s funding request has undergone several rounds of technical review and revision, with stakeholders working to ensure that the proposed interventions reflect national health priorities and meet the Global Fund’s funding requirements.
Investment priorities and health system capacity
The proposed allocation comes as Malawi seeks to sustain progress against HIV, TB, and malaria while addressing health system constraints that affect service delivery.
Investments in resilient health systems are intended to support essential infrastructure, health workforce capacity, supply chains, laboratory services, data systems and the delivery of integrated healthcare.
Linking disease-specific funding with broader health system investments is particularly important for countries that rely on external financing to maintain prevention, diagnosis and treatment programmes.
The approach also supports coordination across programmes that often depend on the same health facilities, laboratories, supply networks and frontline workers.
Malawi is preparing to submit its funding request by the 5 October 2026 deadline.
The final application will set out the country’s proposed priorities and resource requirements for the three-year implementation period beginning in July 2027.
Be the first to leave a comment